Terazosin
Kornam belongs to a group of medicines called alpha-adrenergic receptor antagonists (or alpha-adrenolytics).
Kornam causes a decrease in the tension of the walls of blood vessels (veins and arteries) and their dilation,
which facilitates blood flow through these vessels. The medicine also relaxes the muscles of the prostate and the neck
of the urinary bladder, making it easier to urinate.
Kornam is used to treat high blood pressure, to treat benign prostatic hyperplasia (enlarged prostate), and to treat
symptomatic urinary outflow obstruction due to benign prostatic hyperplasia.
Before starting to take Kornam, discuss it with your doctor or pharmacist.
Kornam can significantly lower blood pressure, causing dizziness, and in severe cases, fainting.
The risk of these disorders occurs after taking the first dose or a few initial doses of the medicine, after
increasing the dose of the medicine, after a break in taking the medicine lasting 2 or more days, and then
resuming treatment, as well as in elderly patients (≥65 years) and after adding another antihypertensive or
diuretic medicine to the treatment.
If you resume taking Kornam after a few-day break, your doctor will recommend using the initial dose.
Patients may experience significant lowering of blood pressure, especially after taking the first dose ("first dose
effect") or after increasing the dose, particularly when standing or changing position. They may then experience
symptoms such as weakness, dizziness, and, in very rare cases, loss of consciousness, sometimes caused by
supraventricular tachycardia.
These symptoms can also be expected when resuming treatment after a break lasting two or more days.
Usually, they only last for a short time and usually disappear after continuing treatment.
Avoid sudden changes in body position or prolonged standing after increasing the dose of the medicine and
resuming treatment after a break. This applies especially to elderly patients. Avoid stressful situations that can
cause fainting, sit or lie down when experiencing any symptoms of low blood pressure, although they do not
always have to be related to body position, and exercise caution when getting up from a sitting or lying
position. If you experience dizziness or palpitations, contact your doctor immediately, who will consider
adjusting the dose.
The medicine should not be taken in case of urinary retention, anuria, or advanced renal failure.
Due to the risk of excessive lowering of blood pressure, caution should be exercised when taking terazosin
(the active substance of Kornam) and thiazide diuretics or other antihypertensive medicines. If these medicines
are added during treatment with terazosin, your doctor will recommend reducing the dose or discontinuing
terazosin. It is necessary to gradually increase the new dose. If terazosin is taken in combination with other
antihypertensive medicines, your doctor will recommend reducing their dose before starting treatment with
terazosin and adjusting their dose when the dose of terazosin is stabilized.
Terazosin may cause prolonged (lasting more than 4 hours) or painful erections (so-called priapism). In case
of its occurrence, you should immediately contact your doctor, as otherwise, there is a risk of permanent
erectile dysfunction.
Before starting treatment for symptoms of benign prostatic hyperplasia, your doctor will perform appropriate
examinations to rule out other causes of urinary outflow obstruction or symptoms from the urinary tract.
Patients with benign prostatic hyperplasia who also have urinary outflow obstruction in the upper urinary tract,
chronic urinary tract infections, or kidney stones should not take Kornam.
Your doctor will carefully monitor the course of treatment in patients with pulmonary edema caused by
mitral valve stenosis or with heart failure.
Concomitant use of Kornam and such medicines as sildenafil, tadalafil, or vardenafil requires special caution
due to the risk of hypotensive symptoms. You should consult your doctor about this.
You should inform your doctor if you have ever fainted after urinating, as Kornam is contraindicated in such
patients.
If you are to undergo surgical treatment for cataracts, you should inform the operating ophthalmologist about
taking Kornam currently or in the past.
Terazosin may affect the results of some blood laboratory tests.
Caution should be exercised when taking medicines that may affect liver metabolism (e.g., 5-phosphodiesterase
inhibitors, such as sildenafil, tadalafil, and vardenafil [medicines used to treat erectile dysfunction], calcium
antagonists, angiotensin-converting enzyme [ACE] inhibitors [medicines used to treat high blood pressure or
certain heart diseases], and cimetidine [a medicine that inhibits gastric acid secretion]).
If you are to undergo a urine test to diagnose a pheochromocytoma (a tumor of the adrenal gland), you must
tell your doctor about taking Kornam.
Kornam should not be taken by children.
Tell your doctor about all medicines you are taking now or have taken recently, as well as about medicines you
plan to take.
Before taking any additional medicine, including over-the-counter medicines, vitamins, and herbal preparations,
consult your doctor. Kornam and other medicines taken at the same time may affect each other's action.
This applies especially to the following medicines:
Tablets should be swallowed with a sufficient amount of liquid (e.g., a glass of water).
During treatment with Kornam, you should avoid consuming alcoholic beverages.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor
before taking this medicine.
The medicine can be taken during pregnancy and breastfeeding only if your doctor considers it necessary.
The medicine should not be taken shortly before delivery.
Kornam significantly affects the ability to drive and use machines.
Especially at the beginning of treatment, dizziness, drowsiness, and/or fainting may occur. You should not drive
vehicles or operate machines for 12 hours after taking the first dose of the medicine, after increasing the dose,
and after resuming treatment with Kornam after a break.
Kornam contains lactose monohydrate.If you have been diagnosed with intolerance to some sugars, you
should contact your doctor before taking the medicine.
This medicine should always be taken according to your doctor's instructions. If you are unsure, consult your
doctor or pharmacist.
Your doctor will prescribe the appropriate dose and decide how often you should take the medicine.
They may change the dose several times before finding the optimal one. Do not change the dose of the medicine
or stop treatment without consulting your doctor. Unless your doctor decides otherwise, you should take the
medicine before bedtime.
Tablets should be swallowed with a sufficient amount of liquid (e.g., a glass of water).
Hypertension
Usually, the initial dose of the medicine is 1 mg (half a 2 mg tablet) before bedtime and should not be
exceeded.
Then, your doctor will gradually increase the dose if necessary until blood pressure is normalized.
Usually, the maintenance dose is between 2 mg and 10 mg per day, taken before bedtime. The maximum daily
dose is 20 mg (in exceptional cases 40 mg).
Benign prostatic hyperplasia
The initial dose is 1 mg per day (half a 2 mg tablet) before bedtime. The dose of the medicine is increased
gradually until clinical improvement is achieved, according to your doctor's instructions. Usually, a daily dose of
10 mg of terazosin is used. The effect of treatment can be observed after 2 weeks of treatment. The best results
are achieved after 4 to 6 weeks, using a dose of 10 mg of terazosin per day. Usually, the maintenance dose is
between 5 mg and 10 mg before bedtime. The maximum daily dose is 20 mg.
Elderly patients
Dose adjustment is not necessary.
Patients with renal impairment
Patient with reduced or absent urine excretion and patients with severe renal impairment should not take
Kornam. If you are unsure, consult your doctor.
Patients with hepatic impairment
Patient with severe hepatic impairment should not take Kornam. If you are unsure whether this applies to you,
consult your doctor.
In case of taking too much of the medicine, consult your doctor immediately, as excessive lowering of blood
pressure is possible.
If you forget to take Kornam at the usual time, take it as soon as possible and continue taking the medicine
according to the previous schedule. Do not take a double dose to make up for the missed dose.
Before deciding to stop treatment, always consult your doctor.
Even if you feel well, do not stop treatment without consulting your doctor.
After a break in taking terazosin lasting several days, treatment should be resumed from the initial dose of 1
mg.
If you have any further questions about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Kornam can cause side effects, although not everybody gets them.
Kornam may cause fainting. After taking the first dose, excessive lowering of blood pressure may occur, causing
dizziness, and in severe cases, fainting.
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1000 people):
Frequency not known(cannot be estimated from the available data):
There have been reports of a variant of the "floppy iris syndrome" known as "intraoperative floppy iris syndrome"
(IFIS), associated with alpha-adrenolytic medicines during cataract surgery.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor, pharmacist,
or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for
Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 22 49 21 301
fax: + 48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 25°C.
Store in the original packaging.
Do not use this medicine after the expiry date stated on the packaging after EXP.
The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of
medicines no longer required. This will help protect the environment.
The active substance of Kornam is terazosin.
2 mg tablets
One tablet contains 2 mg of terazosin in the form of terazosin hydrochloride dihydrate.
The other ingredients are: lactose monohydrate, microcrystalline cellulose, maize starch, talc, colloidal silica,
magnesium stearate, quinoline yellow.
5 mg tablets
One tablet contains 5 mg of terazosin in the form of terazosin hydrochloride dihydrate.
The other ingredients are: lactose monohydrate, microcrystalline cellulose, maize starch, talc, colloidal silica,
magnesium stearate, yellow iron oxide.
2 mg tablets
Yellow, round, flat tablets with beveled edges, with a score line on one side.
5 mg tablets
Yellow-orange, round, flat tablets with beveled edges, with a score line on one side.
Aluminum/PVC film-coated blisters in a cardboard box containing 30 tablets.
Marketing authorization holder
Sandoz GmbH
Biochemiestrasse 10
A-6250 Kundl, Austria
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57
1526 Ljubljana, Slovenia
To obtain more detailed information, please contact:
Sandoz Polska Sp. z o.o.
ul. Domaniewska 50 C
02-672 Warsaw
tel. 22 209 70 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.